Skip to main content
. 2021 Jul 12;14:3123–3128. doi: 10.2147/JIR.S312090

Table 1.

Prevalence and Characteristics of Rheumatoid Factor Antibodies in Patients with COVID-19

Rheumatoid Factor Antibodies COVID (n=129)
Overall prevalence in any RFs, n (%) 26 (20.16)
RF-IgA 13 (10.32)
RF-IgG 8 (6.35)
RF-IgM 12 (9.52)
RF-IgA +RF-IgG 1 (0.78)
RF-IgA +RF-IgM 2 (1.55)
RF-IgG+RF-IgM 2 (1.55)
RF-IgA +RF-IgG+RF-IgM 1 (0.78)

Note: The cutoff values for positivity in all rheumatoid factor antibodies were set >18 kU/L based on the recommendations of the manufacturer.